Alere Inc (ALR) - Medical Equipment - Deals and Alliances Profile

Date: April 12, 2017
Pages: 60
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF6C82E2120EN
Leaflet:

Download PDF Leaflet

Alere Inc (ALR) - Medical Equipment - Deals and Alliances Profile
Summary

Alere Inc (Alere) is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US. Alere offers its products and services to hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers. The company operates through subsidiaries and a network of distributors in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Alere is headquartered in Waltham, Massachusetts, the US.

Alere Inc (ALR) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Alere Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deal Details
Private Equity
Pharos Capital Group Acquires Majority Stake in TechLab
Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million
Partnerships
Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products
VitaPath Genetics Enters Into Licensing Agreement With Alere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics
Alere Enters Into Co-Development Agreement With AT&T
EKF Diagnostics Enters Into Distribution Agreement With Alere
Spartan Bioscience Enters Into Distribution Agreement With Alere
AdnaGen Extends Licensing Agreement With KellBenx
Debt Offering
Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million
Asset Transactions
QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen
Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion
Acquisition
Abbott Labs to Acquire Alere
Alere Acquires US Diagnostics USD60 Million
Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion
Alere Completes Acquisition Of Epocal For Up To US$241 Million
Alere Acquires eScreen for USD296 Million
Arriva Medical Acquires AmMed Direct For US$23 Million
Arriva Medical Acquires Direct Diabetic Source
Alere Completes Acquisition Of Medical Automation System
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million
Alere Acquires Lab Data Systems
Alere Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
Legal and Regulatory
Mar 09, 2017: Alere Provides Update on Arriva Medical
Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation
Jan 04, 2017: Alere Provides Update on Arriva Medical
Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm
Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition
Product News
03/18/2016: Alere Comments on Alere Anticoagulation Monitoring Technology
Other Significant Developments
Dec 28, 2016: Alere Provides Update on Arriva Medical
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Alere Inc, Medical Equipment, Key Facts, 2015
Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Alere Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Alere Inc, Deals By Market, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Pharos Capital Group Acquires Majority Stake in TechLab
Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million
Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical
Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics
Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products
VitaPath Genetics Enters Into Licensing Agreement With Alere
Thermo Fisher Scientific Enters Into Licensing Agreement With Alere
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics
Alere Enters Into Co-Development Agreement With AT&T
EKF Diagnostics Enters Into Distribution Agreement With Alere
Spartan Bioscience Enters Into Distribution Agreement With Alere
AdnaGen Extends Licensing Agreement With KellBenx
Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023
Alere Completes Private Placement Of Notes Due 2020 For US$425 Million
Alere Completes Private Placement Of Notes Due 2018 For US$450 Million
QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen
Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US$5 Billion
Abbott Labs to Acquire Alere
Alere Acquires US Diagnostics USD60 Million
Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion
Alere Completes Acquisition Of Epocal For Up To US$241 Million
Alere Acquires eScreen for USD296 Million
Arriva Medical Acquires AmMed Direct For US$23 Million
Arriva Medical Acquires Direct Diabetic Source
Alere Completes Acquisition Of Medical Automation System
Alere Acquires Arriva Medical From Palm Beach Capital For US$83 Million
Alere Completes Acquisition Of Axis-Shield, Diagnostic Test Maker, For US$389 Million
Alere Acquires Lab Data Systems
Alere Inc, Key Competitors
Alere Inc, Key Employees
Alere Inc, Subsidiaries

LIST OF FIGURES

Alere Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Alere Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

Alere Inc (ALR) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: